Authors:
Kulkarni, R
Scott-Emuakpor, AB
Brody, H
Weil, WB
Ragni, MV
Gera, R
Citation: R. Kulkarni et al., Nondisclosure of human immunodeficiency virus and hepatitis C virus coinfection in a patient with hemophilia: Medical and ethical considerations, J PED H ONC, 23(3), 2001, pp. 153-158
Authors:
Murray, PG
Swinnen, LJ
Flavell, JR
Ragni, MV
Baumforth, KRN
Toomey, SM
Filipovich, AH
Lowe, D
Schnell, CS
Johl, J
Gulley, M
Young, LS
Ambinder, RF
Citation: Pg. Murray et al., Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas, HUMAN PATH, 32(9), 2001, pp. 963-969
Citation: Mv. Ragni et Sh. Belle, Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection, J INFEC DIS, 183(7), 2001, pp. 1112-1115
Authors:
Ragni, MV
Lusher, JM
Koerper, MA
Manco-Johnson, M
Krause, DS
Citation: Mv. Ragni et al., Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophilia, HAEMOPHILIA, 6(2), 2000, pp. 98-103
Authors:
Kay, MA
Manno, CS
Ragni, MV
Larson, PJ
Couto, LB
McClelland, A
Glader, B
Chew, AJ
Tai, SJ
Herzog, RW
Arruda, V
Johnson, F
Scallan, C
Skarsgard, E
Flake, AW
High, KA
Citation: Ma. Kay et al., Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector, NAT GENET, 24(3), 2000, pp. 257-261
Citation: Mv. Ragni et Fa. Bontempo, Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy, J INFEC DIS, 180(6), 1999, pp. 2027-2029
Authors:
Ragni, MV
Belle, SH
Bass, D
Duerstein, S
Kingsley, LA
Citation: Mv. Ragni et al., Clinical characteristics and blood product usage in AIDS-associated lymphoma in haemophiliacs: a case-control study, HAEMOPHILIA, 4(6), 1998, pp. 826-835